Hepatocellular carcinoma and Hepatitis C. Sarin SK. Okuda K: Hepatitis B and C carrier to cancer, pp 315-329 ELSEVIER INDIA 2002 Author:Kiyosawa K, Tanaka E
Hepatitis C virus in the etiology of hepatocellular carcinoma. Tabor E: Virus and Liver Cancer, pp 31-42 ELSEVIER 2002 Author:Kiyosawa K, Tanaka E
論文 Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B J Gastroenterol,55(10):977-989 2020(Oct.) Author:Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Kang JH, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E
Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma Ann Diagn Pathol,48:151587 2020(Oct.) Author:Sato K, Uehara T, Iwaya M, Nakajima T, Miyagawa Y, Ota H, Tanaka E
Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection JGH Open,4(4):574-581 2020(Aug.) Author:Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E
Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus Clin J Gastroenterol,13(1):83-89 2020(Feb.) Author:Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine Clin J Gastroenterol,13(1):1-5 2020(Feb.) Author:Sato K, Suga T, Hirayama A, Daikuhara S, Uehara T, Tanaka E
Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing J Infect Dis,221(3) 2020(Jan.) Author:Sakamoto K, Umemura T, Ito K, Okumura A, Joshita S, Ota M, Sugiyama M, Mizokami M, Yoneda M, Tanaka E
Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis J Gastroenterol Hepatol 2019(Nov.) Author:Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T
Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma Pathol Res Pract,215(11):152623 2019(Nov.) Author:Kuraishi Y, Uehara T, Kobayashi Y, Nakajima T, Watanabe T, Shimizu A, Ota H, Tanaka E:
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis JHEP Rep,1(5):353-360 2019(Nov.) Author:Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M
Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis Hepatol Res,49(10):1236-1243 2019(Oct.) Author:Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society Hepatol Res,49(9):964-980 2019(Sep.) Author:Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H
Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection Medicine (Baltimore),98(30):e16619 2019(Jul.) Author:Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E
What will happen in patients with advanced nonalcoholic fatty liver Hepatobiliary Surg Nutr,8(3):283-285 2019(Jun.) Author:Kimura T, Tanaka N, Tanaka E
Response to the letter by Matsushita et al. regarding our manuscript "Resection Depth and Layer of Cold Snare Polypectomy versus Endoscopic Mucosal Resection" J Gastroenterol,54(5):473 2019(May) Author:Suga T, Ito A, Ota H, Tateiwa N, Matsumoto A, Tanaka E
Red plasma and ascites under ultraviolet A Lancet Gastroenterol Hepatol,4(4):324 2019(Apr.) Author:Wakabayashi SI, Kimura T, Tanaka N, Komatsu M, Tanaka E
A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax Case Rep Oncol Med,:8357893 2019(Mar.) Author:Kako S, Joshita S, Matsuo A, Kawaguchi K, Umemura T, Tanaka E
Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study Medicine (Baltimore),98(6):e14475 2019(Feb.) Author:Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Current status, problems, and perspectives of non-alcoholic fatty liver disease research World J Gastroenterol,25(2):163-177 2019(Jan.) Author:Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals J Viral Hepat,25(12):1462-1471 2018(Dec.) Author:Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E
Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients Hepatol Res,48(13):1092-1098 2018(Dec.) Author:Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E
Resection depth and layer of cold snare polypectomy versus endoscopic mucosal resection J Gastroenterol,53(11):1171-1178 2018(Nov.) Author:Ito A, Suga T, Ota H, Tateiwa N, Matsumoto A, Tanaka E
Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C Cytokine,111:357-363 2018(Oct.) Author:Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E
A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis Sci Rep,8(1):11924 2018(Aug.) Author:Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M
Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma Clin J Gastroenterol,11(4):302-308 2018(Aug.) Author:Wakabayashi SI, Kimura T, Tanaka N, Joshita S, Kawata K, Umemura T, Hiroshima Y, Mori H, Kobayashi H, Wada S, Tanaka E
Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori Clin Endosc,51(4):362-367 2018(Jul.) Author:Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E
Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature Ann Hepatol,17(4):655-660 2018(Jul.) Author:Fujii F, Kimura T, Tanaka N, Kubota D, Sugiura A, Umemura T, Wada S, Tanaka E
A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature J Infect Chemother,24(5):393-397 2018(May) Author:Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma Sci Rep,8(1):7958 2018(May) Author:Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K
Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis Sci Rep,8(1):8159 2018(May) Author:Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E
KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients Oncotarget,9(28):19650-19661 2018(Apr.) Author:Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis World J Gastroenterol,24(13):1440-1450 2018(Apr.) Author:Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society Am J Transplant,18(3):659-668 2018(Mar.) Author:Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S
Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection Hepatol Res,48(4):275-285 2018(Mar.) Author:Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease World J Gastroenterol,24(11):1239-1249 2018(Mar.) Author:Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E
Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection Gut,67(2):362-371 2018(Feb.) Author:Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy J Gastroenterol,53(2):247-257 2018(Feb.) Author:Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E
Genetics and epigenetics in the pathogenesis of primary biliary cholangitis Clin J Gastroenterol,11(1):11-18 2018(Feb.) Author:Joshita S, Umemura T, Tanaka E, Ota M
Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C PLoS One,13(4):e0195632 2018 Author:Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E
Salmonella Enteritidis cholecystitis with chronic granulomatous disease IDCases,12:49-52 2018 Author:Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E
Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population PLoS One,13(4):e0195778 2018 Author:Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M
Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients J Hum Genet,62(11):963-967 2017(Nov.) Author:Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M
Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan Hepatol Res,47(11):1155-1164 2017(Oct.) Author:Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y, The Assessment Committee of Indication for Transplantation
Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury Clin J Gastroenterol,10(5):452-458 2017(Oct.) Author:Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Association between lower air pressure and the onset of ischemic colitis: a case-control study Eur J Gastroenterol Hepatol,29(9):1071-1078 2017(Sep.) Author:Kimura T, Shinji A, Tanaka N, Koinuma M, Yamaura M, Nagaya T, Joshita S, Komatsu M, Umemura T, Horiuchi A, Wada S, Tanaka E
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis Liver Int,37(6):897-905 2017(Jun.) Author:Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody J Gastroenterol,52(3):376-384 2017(May) Author:Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir Case Rep Gastroenterol,11(2):305-311 2017(May) Author:Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N, Tanaka E, Kiyosawa K
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection Hepatol Res,47(5):405-418 2017(Apr.) Author:Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C Sci Rep,7:46705 2017(Apr.) Author:Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population Hum Mol Genet,23(3):650-659 2017(Feb.) Author:Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M
Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis Clin J Gastroenterol,10(1):73-78 2017(Feb.) Author:Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection Hepatol Res,47(2):226-233 2017(Feb.) Author:Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up Clin J Gastroenterol,10(1):79-85 2017(Feb.) Author:Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study J Gastroenterol,52(1):113-122 2017(Jan.) Author:Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
Association between endotoxemia and histological features of nonalcoholic fatty liver disease World J Gastroenterol,23(4):712-722 2017(Jan.) Author:Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study. J Gastroenterol,52(1):113-122 2017(Jan.) Author:Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis J Immunol Res,:3073504 2017 Author:Joshita S, Umemura T, Tanaka E, Ota M
Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis. Clin J Gastroenterol,in press 2016(Dec.) Author:Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan. Hepatol Res,in press 2016(Dec.) Author:Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y
Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res,46(12):1171-1186 2016(Nov.) Author:Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S; Japanese Liver Transplantation Society.
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis. Liver Int,in press 2016(Nov.) Author:Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up. Clin J Gastroenterol,in press 2016(Nov.) Author:Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut,in press 2016(Oct.) Author:Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis. Hepatol Res,46(10):1019-27 2016(Sep.) Author:Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations. BMC Microbiol,16(1):224 2016(Sep.) Author:Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S
Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C. Hepatol Res,46(9):884-9 2016(Aug.) Author:Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E
Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatol Res,46(9):878-83 2016(Aug.) Author:Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M
A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma. Clin J Gastroenterol,9(4):222-7 2016(Aug.) Author:Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O
Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years. Dig Endosc,28(5):607-10 2016(Jul.) Author:Iwaya Y, Yamazaki T, Watanabe T, Seki A, Ochi Y, Hara E, Arakura N, Tanaka E, Hasebe O
Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. Springerplus,5(1):998 2016(Jul.) Author:Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E
Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan. Sci Rep,6:29770 2016(Jul.) Author:Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M
Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody. J Gastroenterol,in press 2016(Jul.) Author:Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C. Hepatology,63(6):2063-4 2016(Jun.) Author:Shibata S, Umemura T, Komatsu M, Tanaka E
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection. Hepatol Res,in press 2016(Jun.) Author:Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy 信州医学雑誌,64(2):75-78 2016(Apr. 10) Author:Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji
Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis. Sci Rep,6:24767 2016(Apr.) Author:Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, et al
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Hepatol Res,in press 2016(Mar.) Author:Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2. Hepatol Res,46(2):129-65 2016(Feb.) Author:Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H
The loop-forming method as a useful technique to rotate the endoscopic insertion tube shaft. Endosc Int Open,4(2):E170-4 2016(Feb.) Author:Suga T, Okamura T, Arakura N, Tanaka E
Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease. Dis Markers,2016:6485343 2016 Author:Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M
Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression. Pathology,47(7):647-52 2015(Dec.) Author:Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H
A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm? Pathol Res Pract,211(12):1034-9 2015(Dec.) Author:Muraki T, Uehara T, Sano K, Oota H, Yoshizawa A, Asaka S, Tateishi A, Otsuki T, Shingu K, Matoba H, Kobayashi S, Ichimata S, Watanabe T, Itou T, Tanaka E
Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B. Hepatol Res,45(12):1195-202 2015(Dec.) Author:Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E
Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine. Acta Histochem Cytochem,48(6):193-204 2015(Dec.) Author:Daikuhara S, Uehara T, Higuchi K, Hosaka N, Iwaya M, Maruyama Y, Matsuda K, Arakura N, Tanaka E, Ota H
Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach. J Gastroenterol Hepatol,30(10):1478-84 2015(Oct.) Author:Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J
A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy. Clin J Gastroenterol,8(5):290-3 2015(Oct.) Author:Okamura T, Komatsu M, Ito A, Ito T, Suga T, Arakura N, Sakai H, Tanaka E
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study. Clin Infect Dis,61(5):719-29 2015(Sep.) Author:Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, et al
Primary hepatocellular carcinoma in a patient with neurofibromatosis type I. Liver Int,35(8):2057-8 2015(Aug.) Author:Kimura T, Tanaka N, Umemura T, Tanaka E
Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis. Hepatol Res,45(7):739-44 2015(Jul.) Author:Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol,110(6):857-64 2015(Jun.) Author:Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E
Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis. PLoS One,10(6):e0131658 2015(Jun.) Author:Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochim Biophys Acta,1852(3):473-81 2015(Mar.) Author:Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clin,3:168-74 2015(Feb.) Author:Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E
Superficially located enlarged lymphoid follicles characterise nodular gastritis. Pathology,47(1):38-44 2015(Jan.) Author:Okamura T, Sakai Y, Hoshino H, Iwaya Y, Tanaka E, Kobayashi M
Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion. World J Gastroenterol,21(2):541-8 2015(Jan.) Author:Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E
Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan PLOS ONE,9(6):e100565 2014(Jun.) Author:Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M
Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B Hepatol Res,44(1):1-8 2014(Jan.) Author:Tanaka, E; Matsumoto, A
STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis DISEASE MARKERS,2014:727393 2014 Author:Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M
Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy HEPATOLOGY RESEARCH,43(7):801-807 2013(Jul.) Author:Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M
Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography DIGESTIVE ENDOSCOPY,25(2):189-196 2013(Mar.) Author:Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E
Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis HUMAN IMMUNOLOGY,74(2):219-222 2013(Feb.) Author:Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M
Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy INTERNAL MEDICINE,52(17):1903-1908 2013 Author:Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E
Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection J Gastroenterol,47(9):1006-1013 2012(Sep.) Author:Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S
2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients Ther Apher Dia,16(4):289-310 2012(Aug.) Author:Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T
Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy Case Rep Gastroenterol,6(2):319-27 2012(Jul.) Author:Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations BMC Med Genet,13:47 2012(Jun.) Author:Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang J. H, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn S. H, Han K. H, Park J. Y, Yuen M. F, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean PLoS One,7(6):e39175 2012(Jun.) Author:Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn S. H, Park J. Y, Hige S, Kang J. H, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M
Hepatic Cerebroside Sulfotransferase Is Induced by PPARalpha Activation in Mice PPAR Res,:174932 2012(May) Author:Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez Frank J, Aoyama T
Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors Hepatol Res,42(4):333-339 2012(Apr.) Author:Tanaka E, Urata Y
Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection HUMAN IMMUNOLOGY,73(3):298-300 2012(Mar.) Author:Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji
Long-term outcome of japanese patients with type 1 autoimmune hepatitis ,56(2):668-676 2012(Feb.) Author:Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M
Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis Hepatology,55(2):506-511 2012(Feb.) Author:Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B Hepatol Res,42(2):139-149 2012(Feb.) Author:Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H
Assessment of safety of using antithrombotic agents during esophagogastroduodenoscopy: rationale and design of the ASAMA Study Shinshu Medical Journal,60(3):143-148 2012 Author:Kasai H, Suga T, Ikeda U, Yoshioka J, Tanaka E, Akamatsu T, for the ASAMA study Investigators
Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol,46(12):1353-1360 2011(Dec.) Author:Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E
Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients J Gastroenterol,46(10):1203-1212 2011(Oct.) Author:Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, P. B. C. Study Group in NHOSLJ
Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C. Antivir Ther,16(7):1073-1080 2011(Oct.) Author:Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography. Intern Med,50(18):1953-1956 2011(Sep.) Author:Iwaya Y, Takenaka K, Akamatsu T, Yamada Y, Haba S, Matsuda K, Nakazawa H, Muraki T, Kaneko Y, Ito T, Sano K, Arakura N, Tanaka E, Ishida F
Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy HEPATOLOGY RESEARCH,41(9):904-909 2011(Sep.) Author:Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C HUMAN MOLECULAR GENETICS,20(17):3507-3516 2011(Sep.) Author:Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M
Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy JOURNAL OF GASTROENTEROLOGY,46(6):758-768 2011(Jun.) Author:Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, Nagaya T, Komatsu M, Sano K, Miyagawa S, Aoyama T, Tanaka E
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C HEPATOLOGY RESEARCH,41(6):587-593 2011(Jun.) Author:Yoneda S, Umemura T, Joshita S, Ichijo T,Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b JOURNAL OF MEDICAL VIROLOGY,83(5):871-878 2011(May) Author:Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M
Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients JOURNAL OF INFECTIOUS DISEASES,203(8):1087-1095 2011(Apr.) Author:Yoneda, Suguru; Umemura, Takeji; Katsuyama, Yoshihiko; Kamijo, Atsushi; Joshita, Satoru; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients HEPATOLOGY RESEARCH,41(4):350-357 2011(Apr.) Author:Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E
Clinical significance of immunoglobulin G4-associated autoimmune hepatitis JOURNAL OF GASTROENTEROLOGY,46(Suppl 1):48-55 2011(Jan.) Author:Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E
Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009 HEPATOLOGY RESEARCH,41(1):1-21 2011(Jan.) Author:Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M
A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture INTERNAL MEDICINE,50(17):1815-1819 2011 Author:Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease JOURNAL OF GASTROENTEROLOGY,45(12):1263-1271 2010(Dec.) Author:Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N
Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib International Journal of Case Reports and Images,1(4):16-18 2010(Dec.) Author:Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E
Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,47(3):256-260 2010(Nov.) Author:Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E
Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice BIOCHEMICAL PHARMACOLOGY,80(10):1601-1612 2010(Nov.) Author:Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T
Down-regulation of SREBP-1c is associated with the development of burned-out NASH JOURNAL OF HEPATOLOGY,53(4):724-731 2010(Oct.) Author:Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T
Chronic gastritis in the setting of autoimmune pancreatitis AMERICAN JOURNAL OF SURGICAL PATHOLOGY,34(9):1241-1249 2010(Sep.) Author:Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H
Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients JOURNAL OF HEPATOLOGY,53(3):537-541 2010(Sep.) Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao
Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice. Redox Rep,15(3):123-130 2010(Jul.) Author:Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T
Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment DIGESTIVE DISEASES AND SCIENCES,55(7):2095-2101 2010(Jul.) Author:Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y
Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits JOURNAL OF GASTROENTEROLOGY,45(6):666-672 2010(Jun.) Author:Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji
A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients HUMAN IMMUNOLOGY,71(5):520-524 2010(May) Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry JOURNAL OF KOREAN MEDICAL SCIENCE,25(3):476-480 2010(Mar.) Author:Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji
Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages DIGESTIVE ENDOSCOPY,22(1):33-38 2010(Jan.) Author:Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan HEPATOLOGY RESEARCH,40(1):1-7 2010(Jan.) Author:Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan HEPATOLOGY RESEARCH,40(1):8-13 2010(Jan.) Author:Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B ShinshuMed J,58(4):153-162 2010 Author:Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E
DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH JOURNAL OF HEPATOLOGY,52(Suppl. 1):S373-S374 2010 Author:Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.
CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS JOURNAL OF HEPATOLOGY,52(Suppl. 1):S286-S286 2010 Author:Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res
A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome INTERNAL MEDICINE,49(11):991-994 2010 Author:Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi;Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji
Combination Chemotherapy with Low-dose 5-FU, Cisplatin, and Gemcitabine for Gemcitabine-Refractory Pancreatic Cancer 信州医学雑誌,57(6):247-253 2009(Dec.) Author:Norikazu ARAKURA, Osamu HASEBE, Yasuhide OCHI, Hideaki HAMANO, Eiji TANAKA, Shigeyuki KAWA Keywords:second-lin chemotherapy, pancreatic cancer, 5-FU, Cisplatin, Gemcitabine
Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study JOURNAL OF GASTROENTEROLOGY,44(9):952-963 2009(Sep.) Author:Okanoue, Takeshi; Itoh, Yoshito; Hashimoto, Hiroaki; Yasui, Kohichiroh; Minami, Masahito; Takehara, Tetsuo; Tanaka, Eiji; Onji, Morikazu; Toyota, Joji; Chayama, Kazuaki; Yoshioka, Kentaro; Izumi, Namiki; Akuta, Norio; Kumada, Hiromitsu
A case of well-differentiated cholangiolocellular carcinoma visualizedwith contrast-enhanced ultrasonography using Sonazoid HEPATOLOGY RESEARCH,39(2):207-212 2009(Feb.) Author:Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji
Pancreaticobiliary Fistula Evident after ESWL Treatment of Pancreatolithiasis INTERNAL MEDICINE,48(7):545-549 2009 Author:Arakura, N; Ozaki, Y; Maruyama, M; Chou, Y; Kodama, R; Takayama, M; Hamano, H; Tanaka, E; Kawa, S
Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults INTERNAL MEDICINE,48(15):1267-1272 2009 Author:Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi
Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis INTERNAL MEDICINE,48(21):1885-1888 2009 Author:Arakura, Norikazu; Ozaki, Yayoi; Yamazaki, Sachie; Ueda, Kazuhiko; Maruyama, Masafumi; Chou, Yoshimi; Kodama, Ryo; Takayama, Mari; Hamano, Hideaki; Tanaka, Eiji; Kawa, Shigeyuki
Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase LIVER INTERNATIONAL,28(8):1104-1111 2008 Author:Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E
Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan CLINICAL INFECTIOUS DISEASES,47(5):E52-E56 2008 Author:Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H
Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis Clinical Immunology,122(3):338-342 2007 Author:Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K
Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C Journal of Viral Hepatitis,14(1):48-54 2007 Author:Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K
Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics JOURNAL OF MEDICAL VIROLOGY,78(1):68-73 2006 Author:Misawa, N; Matsumoto, A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura, T; Maki, N; Kimura, T; Kiyosawa, K
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance LIVER INTERNATIONAL,26(1):90-96 2006 Author:Tanaka, E; Matsumoto, A; Suzuki, F; Kobayashi, M;Mizokami, M; Tanaka, Y; Okanoue, T; Minami, M; Chayama, K; Imamura, M; Yatsuhashi, H; Nagaoka, S; Yotsuyanagi, H; Kawata, S; Kimura, T; Maki, N; Iino, S; Kiyosawa, K
Laparoscopic findings in patients with nonalcoholic steatohepatitis LIVER INTERNATIONAL,26(1):32-38 2006 Author:Tanaka, N; Ichijo, T; Okiyama, W; Mutou, H; Misawa, N; Matsumoto, A; Yoshizawa, K; Tanaka, E; Kiyosawa, K
Timing of interferon therapy and sources of infection in patients with acute hepatitis C HEPATOLOGY RESEARCH,34(1):35-40 2006 Author:Ogata, K; Ide, T; Kumashiro, R; Kumada, H; Yotsuyanagi, H; Okita, K; Akahane, Y; Kaneko, S; Tsubouchi, H;Tanaka, E; Moriwaki, H; Nishiguchi, S; Kakumu, S; Mizokami, M; Iino, S; Sata, M
Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region EUROPEAN JOURNAL OF HAEMATOLOGY,77(3):255-258 2006 Author:Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection HEPATOLOGY,44(2):326-334 2006 Author:Ozasa, A; Tanaka, Y; Orito, E; Sugiyama, M; Kang, JH; Hige, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Okada, S; Tokita, H; Asahina, Y; Inoue, K; Kakumu, S; Okanoue, T; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sakugawa, H; Miyakawa, Y; Ueda, R; Mizokami, M
Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population LIVER INTERNATIONAL,26(8):956-963 2006 Author:Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K
Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy JOURNAL OF GASTROENTEROLOGY,41(8):785-790 2006 Author:Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K
Influence of hepatitis B virus genotypes as well as precore and core-promoter mutations on fulminant outcome of acute infection HEPATOLOGY,44(4):539A-539A 2006 Author:Sugauchi, F; Orito, E; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Yotsuyanagi, H; Iino, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Izumi, N; Inoue, K; Kakumu, S; Tomita, E; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Okanoue, T; Nishiguchi, S; Miyakawa,Y; Mizokami, M
A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan HEPATOLOGY,44(4):228A-228A 2006 Author:Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan HEPATOLOGY RESEARCH,36(2):107-114 2006 Author:Sugauchi, F; Orito, E; Ohno, T; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Ichida, T; Izumi, N; Inoue, K; Hoshino, H; Iino, S; Yotsuyanagi, H; Kakumu, S; Tomita, E; Okanoue, T; Nishiguchi, S; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Miyakawa, Y; Ueda, R; Mizokami, M
Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection ARCHIVES OF VIROLOGY,150(5):883-898 2005 Author:Higashi, K; Tsukiyama-Kohara, K; Tanaka, T; Tanaka, E; Kiyosawa, K; Kohara, M
Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan INTERVIROLOGY,48(4):239-245 2005 Author:Orito, E; Sugauchi, F; Tanaka, Y; Ichida, T; Sata, M; Tanaka, E; Okanoue, T; Sakugawa, H; Watanabe, H; Miyakawa, H; Nishiguchi, S; Kumada, H; Ueda, R; Mizokami, M
Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain JOURNAL OF BIOLOGICAL CHEMISTRY,280(23):21713-21719 2005 Author:Kimura, T; Ohno, N; Terada, N; Rokuhara, A; Matsumoto, A; Yagi, S; Tanaka, E; Kiyosawa, K; Ohno, S; Maki, N
Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan JOURNAL OF VIRAL HEPATITIS,12(4):439-442 2005 Author:Tanaka, E; Matsumoto, A; Takeda, N; Li, TC; Umemura, T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients HEPATOLOGY RESEARCH,32(3):173-184 2005 Author:Matsumoto, A; Tanaka, E; Rokuhara, A; Kiyosawa, K; Kumada, H; Omata, M; Okita, K; Hayashi, N; Okanoue, T; Iino, S; Tanikawa, K
Identification and quantitative analysis of a 22-KDA precore protein lacking C-terminal arginine-rich domain in hepatitis B virus DNA-negative Dane particles. HEPATOLOGY,42(4):708A-708A 2005 Author:Kimura, T; Ohue, C; Ohno, N; Terada, N; Ohno, S; Akinori, R; Matsumoto, A; Tanaka, E; Kiyosawa, K; Maki, N
Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis J Hepatol,42(4):578-584 2005 Author:Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients J Med Virol,77(3):399-413 2005 Author:Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K
Nucleotide mutations associated with hepatitis B e antigen negativity J Med Virol,76(2):170-175 2005 Author:Sun X, Rokuhara A, Tanaka E, Gad A, Mutou H, Matsumoto A, Yoshizawa K, Kiyosawa K
Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection J Gastroenterol Hepatol,20(11):1726-1730 2005 Author:Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K
Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma Asia-Pacific Journal of clinical oncology,1:64-70 2005 Author:Gad A, Tanaka E, Matsumoto A, Serwah Ael-H , Attia F , Hassan A, Ali K , Abbas A, el-Deeb Ael- , Sun X, Umemura T, Ichijyo T, Ehara T, Yoshizawa K, Kiyosawa K
Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma WorldJ Gastroenterol,14:6607-6612 2005 Author:Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K
Hepatitis B virus genotype G is an extremely rare genotype in Japan HEPATOLOGY RESEARCH,30(4):199-203 2004 Author:Kato, H; Sugauchi, F; Ozasa, A; Kato, T; Tanaka, Y; Sakugawa, H; Sata, M; Hino, K; Onji, M; Okanoue, T; Tanaka, E; Kawata, S; Suzuki, K; Hige, S; Ohno, T; Orito, E; Ueda, R; Mizokami, M
Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green Intem Med,43(4):283-288 2004 Author:Umino J, Tanaka E, Ichijoh T, Muraki T, Orii K, Yoshizawa K, Kiyosawa K
Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C N Engl J Med,350(12):1264-1265 2004 Author:Tanaka .N, Ishida F, Tanaka E
Nagano Interferon Treatment Research Group: Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C:analysis by a prospective study J Gastroenterol,39(7):674-680 2004 Author:Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K
Hepatocellular carcinoma: recent trends in Japan Gastroenteroiogy,127(5):S17-S26 2004 Author:Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E
Inteferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death J ViralHepat,11(2):148-156 2004 Author:Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting abiochemical response J Gastroenterol,39(11):1069-1077 2004 Author:Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage Hepatology,40(4):972-980 2004 Author:Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, TanakaE, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T
Riskfactors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy JOURNAL OF HEPATOLOGY,38(2):200-207 2003 Author:Imamura, H; Matsuyama, Y; Tanaka, E; Ohkubo, T; Hasegawa, K; Miyagawa, S; Sugawara, Y; Minagawa, M; Takayama, T; Kawasaki, S; Makuuchi, M
Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities HEPATOLOGY RESEARCH,25(2):124-134 2003 Author:Fujiwara, K; Yokosuka, O; Imazeki, F; Saisho, H; Saotome, N; Suzuki, K; Okita, K; Tanaka, E; Omata, M
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; A marker distinct from viral DNA for monitoring lamivudine treatment. HEPATOLOGY,38(4):726A-727A 2003 Author:Rokuhara, A; Kimura, T; Matsumoto, A; Tanaka, E; Maki, N; Kiyosawa, K
Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease Tissue Antigens,61(2):159-165 2003 Author:Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, Orii K, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
A case-control study for early prediction ofhepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter J Med Virol,70(4):545-552 2003 Author:Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis J Infect Dis,188(10):1545-1552 2003 Author:Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment J Viral Hepat,10(4):324-330 2003 Author:Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K
Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan Clin Infect Dis,37(8):1067-1072 2003 Author:Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T
New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA J Clin Microbiol,41(5):1901-1906 2003 Author:Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N
Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence J Med Virol,70(4):594-599 2003 Author:Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K
Clinical significance of SEN virus infection in patients on maintenance haemodialysis Nephrol Dial Transplant,18(2):348-352 2003 Author:Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima T, Higuchi M, Hora K, Kiyosawa K
Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes CELL TRANSPLANTATION,11(5):407-415 2002 Author:Kakegawa, T; Ise, H; Sugihara, N; Nikaido, T; Negishi, N; Akaike, T; Tanaka, E
The role of SEN virus infection in various liver diseases from different geographical regions. HEPATOLOGY,36(4):646A-646A 2002 Author:Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ
Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines Cancer,95(10):2243-2251 2002 Author:Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K
Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy J Gastroenterol Hepatol,17(11):1229-1235 2002 Author:Yamaura T, Matsumoto A, Rokuhara A, Ichijo T, Tanaka E, Hanazaki K, Kajikawa S, Kiyosawa K
SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C Hepatology,35(4):953-959 2002 Author:Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K
Characteristics of hepatocellular carcinoma in Japan Oncology,62:5-7 2002 Author:Kiyosawa K, Tanaka E
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load J Clin Microbiol,40(2):439-445 2002 Author:Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N
Epidemiology and clinical aspects on hepatitis C Jpn J Infect Dis,55(3):69-77 2002 Author:Higuchi M, Tanaka E, Kiyosawa K
Clinical significance of TT virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection Hepatol Res,22(1):13-19 2002 Author:Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, El-Hamid Serwah A,El-Sherif A, El-Essawy M, Yoshizawa K, Kiyosawa K
Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B JOURNAL OF GASTROENTEROLOGY,36(2):139-141 2001 Author:Kiyosawa, K; Tanaka, E
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene FOOD AND CHEMICAL TOXICOLOGY,39(6):557-561 2001 Author:Hosaka, S; Kawa, S; Aoki, Y; Tanaka, E; Yoshizawa, K; Karasawa, Y; Hosaka, N
A birth cohort study of the seroepidemiologic association of Helicobacter pylori infection and Hepatitis A virus in rural Japan GASTROENTEROLOGY,120(5):A128-A128 2001 Author:Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, ET; Kiyosawa, K; Graham, DY; Katsuyama, T
Development of a sensitive enzyme-immunoassay for hepatitis B virus core-related antigens. CLINICAL CHEMISTRY,47(6):A94-A94 2001 Author:Kimura, T; Rokuhara, A; Sakamoto, Y; Yagi, S; Tanaka, E; Kiyosawa, K; Maki, N
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan HEPATOLOGY,34(3):590-594 2001 Author:Orito, E; Ichida, T; Sakugawa, H; Sata, M; Horiike, N; Hino, K; Okita, K; Okanoue, T; Iino, S; Tanaka, E; Suzuki, K; Watanabe, H; Hige, S; Mizokami, M
8-year birth cohort study of the seroepidemiology of Helicobacter pylori infection and hepatitis A virus in rural Japan GUT,49:A32-A32 2001 Author:Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, T; Kiyosawa, K; Graham, DY
SEN virus infection in high- and non-endemic areas for hepatitis C in Japan. HEPATOLOGY,34(4):487A-487A 2001 Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
Association between SEN virus infection and hepatitis C in Japan JOURNAL OF INFECTIOUS DISEASES,184(10):1246-1251 2001 Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect JOURNAL OF GASTROENTEROLOGY,36(11):753-758 2001 Author:Gad, A; Tanaka, E; Orii, K; Rokuhara, A; Nooman, Z; Serwah, AH; Shoair, M; Yoshizawa, K; Kiyosawa, K
Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay J Gastroenterol,36(5):317-321 2001 Author:Tanaka E 他10名
Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,15(3):311-319 2000 Author:Iijima, A; Tanaka, E; Kobayashi,M; Yagi, S; Mizokami, M; Kiyosawa, K
Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection JOURNAL OF CLINICAL MICROBIOLOGY,38(5):1971-1973 2000 Author:Malaty, HM; Kumagai, T; Tanaka, E; Ota, H; Kiyosawa, K; Graham, DY; Katsuyama, T
Analysis of T cell repertoire in the liver of patients with chronic hepatitis C CLINICAL AND EXPERIMENTAL IMMUNOLOGY,121(1):120-126 2000 Author:Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa,K
Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy. GASTROENTEROLOGY,118(4):A916-A916 2000 Author:Imamura, H; Tanaka, E; Matsuyama, Y; Miyagawa, SI; Kawasaki, S; Kubota, K; Takayama, T; Makuuchi, M
T cell repertoire in the liver of patients with primary biliary cirrhosis HUMAN IMMUNOLOGY,61(7):675-683 2000 Author:Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Tanaka, E; Kiyosawa, K
A new era of interferon treatment for chronic hepatitis C is coming JOURNAL OF GASTROENTEROLOGY,35(8):652-654 2000 Author:Kiyosawa, K; Tanaka, E
The role of hepatitis C virus infection in glomerulopathy HEPATOLOGY RESEARCH,18(3):190-202 2000 Author:Muramatsu, T; Hora, K; Ako, S; Tachibana, N; Hora, K; Tanaka, E
De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome JOURNAL OF MEDICAL VIROLOGY,62(4):471-478 2000 Author:Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
De novo infection of hepatitis B virus in patients with orthotopic liver transplantation analysis by determining the complete sequence of the genome. HEPATOLOGY,32(4):597A-597A 2000 Author:Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease. HEPATOLOGY,32(4):381A-381A 2000 Author:Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa, K; Primi, D
Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,15(11):1292-1297 2000 Author:Nishizawa, Y; Tanaka, E; Orii, K; Rokuhara, A; Ichijo, T; Yoshizawa, K; Kiyosawa, K
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA Hepatology,32(2):388-393 2000 Author:Tanaka E 他6名
Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus Intervirology,43(3):139-145 2000 Author:Orii K, Tanaka E 他5名
Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt J Med Virol,60(2):177-181 2000 Author:Amal G, Tanaka E 他6名
Natural history of acute hepatitis C J Gastroenterol Hepatol,15 (suppl):E97-E104 2000 Author:Tanaka E 他1
Detection of GB virus-C hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue JOURNAL OFMEDICAL VIROLOGY,57(2):114-121 1999 Author:Kobayashi, M; Tanaka, E; Nakayama, J; Furuwatari, C; Katsuyama, T; Kawasaki, S; Kiyosawa, K
TT virus infection in an area of high-endemicity for hepatitisC HEPATOLOGY RESEARCH,13(3):212-220 1999 Author:Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
Transmission of and liver injury by TT virus in patients on maintenance hemodialysis JOURNAL OF GASTROENTEROLOGY,34(2):234-240 1999 Author:Oguchi, T; Tanaka, E; Orii, K; Kobayashi, M; Hora, K; Kiyosawa, K
Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis HEPATOLOGY RESEARCH,14(2):161-170 1999 Author:Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen JOURNAL OF CLINICAL MICROBIOLOGY,37(6):1802-1808 1999 Author:Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
Transfusion-associated TT virus infection and its relationship to liver disease HEPATOLOGY,30(1):283-288 1999 Author:Matsumoto, A; Yeo, AET; Shih, JWK; Tanaka, E; Kiyosawa, K; Alter, HJ
Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination DNA AND CELL BIOLOGY,18(8):611-621 1999 Author:Vidalin, O; Tanaka, E; Spengler, U; Trepo, C; Inchauspe, G
GB virus C/hepatitis G virus INTERVIROLOGY,42(2-3):185-195 1999 Author:Kiyosawa, K; Tanaka, E
T cell repertoire in the liver ofpatients with autoimmune hepatitis HUMAN IMMUNOLOGY,60(9):806-815 1999 Author:Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K
Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro JOURNAL OF GENERAL VIROLOGY,80:3007-3018 1999 Author:Rumin, S; Berthillon, P; Tanaka, E; Kiyosawa, K; Trabaud, MA; Bizollon, T; Gouillat, C; Gripon, P; Guguen-Guillouzo, C; Inchauspe, G; Trepo, C
Does GBV-C/HGV replicate in the liver? JOURNAL OF GASTROENTEROLOGY,34(6):721-723 1999 Author:Tanaka, E
Acquisition and loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study. GASTROENTEROLOGY,114(4):A190-A190 1998 Author:Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
Two patients with acute hepatitis B with suspected sexual transmission of hepatitis G virus JOURNAL OF GASTROENTEROLOGY,33(3):419-423 1998 Author:Tanaka, E; Nakatsuji, Y; Kobayashi, M; Orii, K; Kiyosawa, K
Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C JOURNAL OF GASTROENTEROLOGY,33(4):508-511 1998 Author:Kobayashi, M; Tanaka, E; Matsumoto, A; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,13(6):604-609 1998 Author:Kobayashi, M; Tanaka, E; Oguchi, H; Hora, K; Kiyosawa, K
Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study JOURNAL OF INFECTIOUS DISEASES,178(3):717-721 1998 Author:Kumagai, T; Malaty, HM; Graham, DY; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
An 8-year birth cohort study shows adult-to-child transmission of H-pylori infection GUT,43:A40-A40 1998 Author:Malaty, HM; Kumagai, T; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Acquistion vs. loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study GUT,43:A39-A39 1998 Author:Kumagai, T; Malaty, HM; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Development of highly sensitive enzyme-immunoassay for hepatitis C virus core antigen. HEPATOLOGY,28(4):568A-568A 1998 Author:Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
T cell receptor usage of liver infiltrating T cells in patients with autoimmune hepatitis. HEPATOLOGY,28(4):191A-191A 1998 Author:Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Imai, H; Tanaka, E; Kiyosawa, K
Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case TRANSPLANTATION PROCEEDINGS,30(7):3321-3323 1998 Author:Kita, Y; Lake, JR; Ferrell, LD; Mori, M; Roberts, JP; Kakizoe, S; Kiyosawa, K; Tanaka, E; Shiga, J; Takikawa, H; Inoue, Y; Ohtake, T; Ohtomo, K; Yotsuyanagi, H; Oka, T; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Hashikura, Y; Kawasaki, S; Ascher, NL; Makuuchi, M
Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic J Clin Microbiol,36(1):110-114 1998 Author:Tanaka E 他8名
Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis J Viral Hepatitis,5(3):153-159 1998 Author:TANAKA Eiji 他7名
Hepatitis G virus GB virus C infection in patients with chronic non-B, non-C hepatitis INTERNATIONAL HEPATOLOGY COMMUNICATIONS,6(3-4):137-143 1997 Author:Tanaka, E; Yamaguchi, K; Uemura, K; Kobayashi, M; Iijima, A; Kiyosawa, K; Yagi, S; Hasegawa, A
Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(1):73-76 1997 Author:Kobayashi, M; Tanaka, E; Matsumoto, A; Ichijo, T; Kiyosawa, K
Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection INTERNATIONAL HEPATOLOGY COMMUNICATIONS,6(5):219-224 1997 Author:Ichijo, T; Nakatsuji, Y; Tanaka, E; Alter, HJ; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
A prospective trial to change the administration dose of interferon according to a decrease in serum HCV-RNA in chronic hepatitis C. GASTROENTEROLOGY,112(4):A1386-A1386 1997 Author:Sodeyama, T; Matsumoto, A; Tanaka, E; Iizima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(7):500-506 1997 Author:Ichijo, T; Matsumoto, A; Kobayashi, M; Furihata, K; Tanaka, E
Hepatitis G virus GB virus C infection in an area of high endemic hepatitis C virus infection HEPATOLOGY RESEARCH,7(2):130-135 1997 Author:Tanaka, E; Nakatsuji, Y; Kobayashi, M; Iijima, A; Ichijo, T; Imai, H; Yoshizawa, K; Sodeyama, T; Kiyosawa, K
Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma. HEPATOLOGY,26(4):1599-1599 1997 Author:Iijima, A; Sodeyama, T; Inada, H; Ichijo, T; Kobayashi, M; Yamada, S; Imai, H; Yoshizawa, K; Tanaka, E; Kiyosawa, K
Past and present infections ofhepatitis G virus in high-endemic area for hepatitis C; Comparison with nonendemic area. HEPATOLOGY,26(4):797-797 1997 Author:Tanaka, E; Tacke, M; Kobayashi, M; Nakatsuji, Y; Kiyosawa, K; Schmolke, S; Engel, AM; Hess, G; Alter, HJ
Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery frominfection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors HEPATOLOGY,26(6):1626-1633 1997 Author:Tacke, M; Schmolke, S; Schlueter, V; Sauleda, S; Esteban, JI; Tanaka, E; Kiyosawa, K; Alter, HJ; Schmitt, U; Hess, G; OfenlochHaehnle, B; Engel, AM
Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(11):762-765 1997 Author:Ideura, T; Tanaka, E; Nakatsuji, Y; Kobayashi, M; Kanno, Y; Oguchi, H; Hora, K
Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA) JOURNAL OF IMMUNOLOGICAL METHODS,190(1):79-89 1996 Author:Kashiwakuma, T; Hasegawa, A; Kajita, T; Takata, A; Mori, H; Ohta, Y; Tanaka,E;Kiyosawa, K; Tanaka, T; Tanaka, S; Hattori, N; Kohara, M
Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,11(8):697-704 1996 Author:Mori, H; Yabu, K; Yoshizawa, K; Tanaka, E; Kiyosawa, K
Hepatitis G virus (HGV) infection in Japanese patients infected with hepatitis C virus (HCV). HEPATOLOGY,24(4):403-403 1996 Author:Nakatsuji, Y; Shih, JWK; Kobayashi, M; Tanaka, E; Kiyosawa, K; Kim, JP; Alter, HJ
Effect of hepatitis G virus co-infection on patients with chronic hepatitis C HEPATOLOGY,24(4):400-400 1996 Author:Tanaka, E; Alter, HJ; Nakatsuji, Y; Shih, JWK; Kim, JP; Matsumoto, A; Kobayashi, M; Kiyosawa, K
Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis THROMBOSIS AND HAEMOSTASIS,76(4):545-548 1996 Author:Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
Prevalence and disease association of hepatitis G virus infection in Japan JOURNAL OF VIRAL HEPATITIS,3(6):307-316 1996 Author:Nakatsuji, Y; Shih, JWK; Tanaka, E; Kiyosawa, K; Wages, J; Kim, JP; Alter, HJ
Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder INTERNAL MEDICINE,35(11):871-875 1996 Author:Usui, T; Kitano, K; Midorikawa, T; Yoshizawa, K; Kobayashi, H; Tanaka, E; Matsunami, H; Kawasaki, S; Kiyosawa, K
The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses Hepatology,23(4):695-699 1996 Author:Kobayashi M, Tanaka E 他4名
Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa Hepatology,23(6):1330-1333 1996 Author:Tanaka E 他7名
Effect of hepatitis G virus infection on chronic hepatitis C Ann Intern Med,125(9):740-743 1996 Author:Tanaka E 他8名
USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY JOURNAL OF MEDICAL VIROLOGY,46(2):162-168 1995 Author:SUZUKI, T; TANAKA, E; MATSUMOTO, A; URUSHIHARA, A; SODEYAMA, T
SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA HEPATOLOGY,22(4):996-996 1995 Author:TANAKA, T; LAU, JYN; MIZOKAMI, M; ORITO, E; TANAKA, E; KIYOSAWA, K; YASUI, K; OHTA, Y; HASEGAWA, A; TANAKA, S; KOHARA, M
CLINICAL-APPLICATION OF A FLUORESCENCE ENZYME-IMMUNOASSAY FOR HCV CORE PROTEIN HEPATOLOGY,22(4):995-995 1995 Author:TANAKA, E; MATSUMOTO, A; KOBAYASHI, M; ICHIJO, T; IMAI, H; SODEYAMA, T; KIYOSAWA, K; OHTA, Y; HASEGAWA, A; KOHARA, M
PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN JAPAN HEPATOLOGY,22(4):303-303 1995 Author:NAKATSUJI, Y; SHIH, JWK; TANAKA, E; WAGES, J; KIYOSAWA, K; KIM, JP; ALTER, HJ
ACUTE HEPATITIS-C TRANSMITTED BY NEEDLESTICK ACCIDENT DESPITE SHORT-DURATION INTERFERON TREATMENT JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,10(5):609-611 1995 Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; MATSUMOTO, A; ICHIJO, T; MIZOKAMI, M; FURUTA, S
EPIDEMIOLOGY OF GENOTYPES OF HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITHTYPE-C CHRONIC LIVER-DISEASES - A MULTI-INSTITUTION ANALYSIS JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,10(5):538-545 1995 Author:TANAKA, E; KIYOSAWA, K; MATSUSHIMA, T; ISHIKAWA, K; HINO, K; TANAKA, S; NOSE, H; KUMADA, H; IINO, S; KAMIMURA, T; UNOURA, M; MIZOKAMI, M; OKANOUE, T; KUROKI, T; YAMADA, G; MIURA, T; YANO, M; TSUBOUCHI, H; KOHARA, M; SATO, S; HATTORI, N; FURUTA, S; KARINO, Y; SAINOKAMI, S; TANAKA, T; OKADA, S; CHAYAMA, K; YASUDA, K; KUWANA, K; KANEKO, S; MIZOGUCHI, N; YASUI, K; TAKEDA, T; KISHI, F; YATSUHASHI, H; MARUYAMA, T; TSUKIYAMAKOHARA, K
Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia JOURNAL OF HEPATOLOGY,23(6):742-745 1995 Author:Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
QUANTITATIVE ASSAY FOR ANTI-HCV-CORE ANTIBODY IN HEALTHY-INDIVIDUALS FOUND ANTI-HCV POSITIVE DURING A MASS-SCREENING INTERNATIONAL HEPATOLOGY COMMUNICATIONS,2(1):47-51 1994 Author:URUSHIHARA, A; SUZUKI, T; MATSUMOTO, A; TANAKA, E; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
TYPE C CHRONIC HEPATITIS ASSOCIATED WITH THROMBOCYTOPENIA IN 2 PATIENTS JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,9(1):99-104 1994 Author:YABU, K; KIYOSAWA, K; AKO, S; USUDA, S; YOSHIZAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
CHANGES IN ANTIBODY-TITERS TO HEPATITIS-C VIRUS FOLLOWING INTERFERON THERAPY FOR CHRONIC INFECTION JOURNAL OF MEDICAL VIROLOGY,42(4):348-356 1994 Author:URUSHIHARA, A; SODEYAMA, T; MATSUMOTO, A; TANAKA, E
SILENT HEPATITIS-B VIRUS MUTANTS ARE RESPONSIBLE FOR NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS MICROBIOLOGY AND IMMUNOLOGY,38(4):281-285 1994 Author:UCHIDA, T; SHIMOJIMA, M; GOTOH, K; SHIKATA, T; TANAKA, E; KIYOSAWA, K
ADAPTATION OF HEPATITIS-C VIRUS FOR PERSISTENT INFECTION IN PATIENTS WITH ACUTE HEPATITIS GASTROENTEROLOGY,106(5):1344-1348 1994 Author:YAMAGUCHI, K; TANAKA, E; HIGASHI, K; KIYOSAWA, K; MATSUMOTO, A; FURUTA, S; HASEGAWA, A; TANAKA, S; KOHARA, M
SERUM COLLAGEN TYPE-IVFOR THE ASSESSMENT OF FIBROSIS AND RESISTANCE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,29(5):474-479 1994 Author:YABU, K; KIYOSAWA, K; MORI, H; MATSUMOTO, A; YOSHIZAWA, K; TANAKA, E; FURUTA, S
TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION GASTROENTEROLOGY,106(6):1596-1602 1994 Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; YOSHIZAWA, K; YABU, K; FURUTA, K; IMAI, H; NAKANO, Y; USUDA, S;UEMURA, K; FURUTA, S; WATANABE, Y; WATANABE, J; FUKUDA, Y; TAKAYAMA, T; URUSHIBARA, A; MATSUMOTO, A; MORI, H; KOBAYASHI, M; SUZUKI, T; YAMADA, S; SEKI, T; SHIMIZU, S; NAKAMURA, M; SONE, H; HARA, K; ICHIJO, T; OHIKE, Y; GIBO, Y; NAKATSUJI, Y; YODA, H; TSUCHIYA, K; HAYATA, T; IMAI, Y; KOBAYASHI, M; HARA, N
VIRAL AND HOST FACTORS THAT CONTRIBUTE TO EFFICACY OF INTERFERON-ALPHA(2A) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C DIGESTIVE DISEASES AND SCIENCES,39(6):1273-1280 1994 Author:MATSUMOTO, A; TANAKA, E; SUZUKI, T; OGATA, H; KIYOSAWA, K
PREVALENCE OF HEPATITIS-C VIRUS WITH DIFFERENT GENOTYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY-ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASES DUE TO HEPATITIS-C VIRUS-INFECTION JAPANESE JOURNAL OF MEDICAL SCIENCE&BIOLOGY,47(1):47-57 1994 Author:TANAKA, E; KIYOSAWA, K; MATSUMOTO, A; SODEYAMA, T; URUSHIHARA, A; SUZUKI, T; KOBAYASHI, M; FURUTA, S
IMMUNOPEROXIDASE STAINING OF HEPATITIS-C VIRUS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED NEEDLE LIVER BIOPSIES VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY,424(5):465-469 1994 Author:UCHIDA, T; SHIKATA, T; TANAKA, E; KIYOSAWA, K
NATURAL-HISTORY OF HEPATITIS-C INTERVIROLOGY,37(2):101-107 1994 Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
CLINICAL-SIGNIFICANCE OF ANTIBODIES TO NONSTRUCTURAL AND CORE PROTEINS OF HEPATITIS-C VIRUS IN POSTTRANSFUSION HEPATITIS PATIENTS DURING LONG-TERM FOLLOW-UP JOURNAL OF MEDICAL VIROLOGY,39(4):318-324 1993 Author:TANAKA, E; KIYOSAWA, K; NAKATSUJI, Y; INOUE, Y; MIYAMURA, T; CHIBA, J; FURUTA, S
COMPARISON OF THE CLINICAL AND IMMUNOGENETIC FEATURES BETWEEN PATIENTS WITH AUTOIMMUNE HEPATITIS AND PATIENTS WITH TYPE-C CHRONICACTIVE HEPATITIS GASTROENTEROLOGIA JAPONICA,28:63-68 1993 Author:KIYOSAWA, K; SEKI, T; TANAKA, E; SODEYAMA, T; FURUTA, K; FURUTA, S; HINO, K; OTA, M; INOKO, H
ANTI-C100 ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION TREATED WITH INTERFERON SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,28(4):335-342 1993 Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; YOSHIZAWA, K; FURUTA, K; NAKATSUJI, Y; URUSHIHARA, A; FURUTA, S
COMPARISON OF SEROEPIDEMIOLOGY OF HEPATITIS-C IN BLOOD-DONORS BETWEEN BANGLADESH AND JAPAN GASTROENTEROLOGIA JAPONICA,28:28-31 1993 Author:KHAN, M; HUSAIN, M; YANO, M; HASHIZUME, K; YOUSUF, M; TANAKA, E; MATSUMOTO, A; FURUTA, S; KIYOSAWA, K
PROLIFERATIVE ACTIVITY OF HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS AS REVEALED BY IMMUNOHISTOCHEMISTRY FOR PROLIFERATING CELL NUCLEAR ANTIGEN HUMAN PATHOLOGY,24(7):750-753 1993 Author:NAKAMURA, T; HAYAMA, M; SAKAI, T; HOTCHI, M; TANAKA, E
ASSOCIATION OF PRIMARY BILIARY-CIRRHOSIS WITH HUMAN-LEUKOCYTE ANTIGEN-DPB1-ASTERISK-0501 IN JAPANESE PATIENTS HEPATOLOGY,18(1):73-78 1993 Author:SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; KUMAGAI, T; MIZUKI, N; ANDO, A; INOKO, H
DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS ARCHIVES OF INTERNAL MEDICINE,153(13):1565-1572 1993 Author:SODEYAMA, T; KIYOSAWA, K; URUSHIHARA, A; MATSUMOTO, A; TANAKA, E; FURUTA, S; AKAHANE, Y
PROGNOSIS OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS ANNALS OF INTERNAL MEDICINE,119(6):535-535 1993 Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E
LOW-PREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-1 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,8(5):442-447 1993 Author:TANAKA, E; KIYOSAWA, K; SEKI, T; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; KUMAGAI, T; KOHARA, M
FACTORS THAT CONTRIBUTE TO THE EFFICACY OF IFN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C HEPATOLOGY,18(4):A258-A258 1993 Author:TANAKA, E; MATSUMOTO, A; SUZUKI, T; URUSHIHARA, A; YOSHIZAWA, K; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
IMMUNE-RESPONSES TO HCV ANTIGENS OF THE PATIENTS WITH DIFFERENT HISTOLOGICAL STAGES IN CHRONIC HEPATITIS-C HEPATOLOGY,18(4):A245-A245 1993 Author:MORI, H; YABU, K; YOSHIZAWA, K; USUDA, S; TANAKA, E; KIYOSAWA, K; HASEGAWA, A; KOHARA, M; FURUTA, S
HUMAN-LEUKOCYTE ANTIGEN CLASS-II MOLECULES AND PRIMARY BILIARY-CIRRHOSIS SUSCEPTIBILITY IN JAPANESE PATIENTS HEPATOLOGY,18(4):A218-A218 1993 Author:SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; MIZUKI, N; ANDO, A; INOKO, H
HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEAVY DRINKERS WITH CHRONIC LIVER-DISEASES IN JAPAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,7(1):30-35 1992 Author:SHIMIZU, S; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, M
PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE SCHOOLCHILDREN - COMPARISON WITH ADULT-BLOODDONORS AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE,46(4):460-464 1992 Author:TANAKA, E; KIYOSAWA, K; SODEYAMA, T; HAYATA, T; OHIKE, Y; NAKANO, Y; YOSHIZAWA, K; FURUTA, S; WATANABE, Y; WATANABE, I; NISHIOKA, K
HEPATITIS-VIRUS INFECTION (HBV AND HCV) IN 11 JAPANESE HEMODIALYSIS UNITS CLINICAL NEPHROLOGY,38(1):36-43 1992 Author:OGUCHI, H; MIYASAKA, M; TOKUNAGA, S;HORA, K; ICHIKAWA, S; OCHI, T; YAMADA, K; NAGASAWA, M; KANNO, Y; AIZAWA, T; WATANABE, H; YOSHIZAWA, S; SATO, K; TERASHIMA, M; YOSHIE, T; OGUCHI, S; TANAKA, E; KIYOSAWA, K; FURUTA, S
DETECTION OF CHRONIC HEPATITIS-C VIRUS-INFECTION BY 4 DIAGNOSTIC SYSTEMS - 1ST-GENERATION AND 2ND-GENERATION ENZYME-LINKED-IMMUNOSORBENT-ASSAY, 2ND-GENERATION RECOMBINANT IMMUNOBLOT ASSAY AND NESTED POLYMERASE CHAIN-REACTION ANALYSIS HEPATOLOGY,16(2):300-305 1992 Author:NAKATSUJI, Y; MATSUMOTO, A; TANAKA, E; OGATA, H; KIYOSAWA, K
NEW HEPATOCELLULAR-CARCINOMA CELL-LINE SUHC-1 ESTABLISHED FROM A PATIENT WITH HEPATITIS-C VIRUS-RNA IN SERUM JAPANESE JOURNAL OF CANCER RESEARCH,83(8):871-877 1992 Author:YOSHIZAWA, K; KIYOSAWA, K; USUDA, S; YABU, K; NAKATSUJI, Y; YAMADA, S; FURUTA, K; TANAKA, E; SODEYAMA, T; FURUTA, S; KANEKO, S; NAKANE, PK
PERSISTENCE OF VIREMIA IN PATIENTS WITH TYPE-C CHRONIC HEPATITIS DURING LONG-TERM FOLLOW-UP SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,27(9):812-816 1992 Author:YOUSUF, M; NAKANO, Y; TANAKA, E; SODEYAMA, T; KIYOSAWA, K
IMMUNOSUPPRESSIVE THERAPY PROMOTES THE REPLICATION OF HEPATITIS-C VIRUS, FOLLOWED BY EXACERBATION OF LIVER-DISEASE AFTER DOSAGE REDUCTION OR WITHDRAWAL HEPATOLOGY,16(4):A215-A215 1992 Author:NAKATSUJI, Y; KIYOSAWA, K; FURIHATA, K; TANAKA, E; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; MAKUUCHI, M
PERFORMANCE OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM FOR ANTIBODIES TO HEPATITIS-C VIRUS WITH 2 NEW ANTIGENS (C11/C7) CLINICAL CHEMISTRY,38(12):2434-2439 1992 Author:SAITO, M; HASEGAWA, A; KASHIWAKUMA, T; KOHARA, M; SUGI, M; MIKI, K; YAMAMOTO, T; MORI, H; OHTA, Y; TANAKA, E; KIYOSAWA, K; FURUTA, S; WAKASHIMA, M; TANAKA, S; HATTORI, N
A HIGH PREVALENCE OF ANTIBODY TO THE HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN JAPAN CANCER,67(2):429-433 1991 Author:NISHIOKA, K; WATANABE, J; FURUTA, S; TANAKA, E; IINO, S; SUZUKI, H; TSUJI, T; YANO, M; KUO, G; CHOO, QL; HOUGHTON, M; ODA, T
SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITH VIRAL-HEPATITIS - RELATIONSHIP BETWEEN ANTI-HCV ANTIBODY AND THE PROGNOSIS OF NON-A, NON-B POSTTRANSFUSION HEPATITIS JOURNAL OF MEDICAL VIROLOGY,33(2):117-122 1991 Author:TANAKA, E; KIYOSAWA, K; SODEYAMA, T; NAKANO, Y; YOSHIZAWA, K; HAYATA, T; SHIMIZU, S; NAKATSUJI, Y; KOIKE, Y; FURUTA, S
INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS IN JAPAN JOURNAL OF MEDICAL VIROLOGY,33(2):114-116 1991 Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; SHIMIZU, S; FURUTA, S; MIYAZAKI, Y; AKAHANE, Y; SUZUKI, H
EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN SUBTYPES IN LIVER OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA - COMPARISON OF SUBTYPES IN SERUM AND LIVER LIVER,11(3):176-184 1991 Author:NAKATSUJI, Y; KIYOSAWA, K; TANAKA, E; SODEYAMA, T; HORIGOME, N; KAJIKAWA,S; NAITO, S; AKAHANE, Y
HEPATITIS-C IN HOSPITAL EMPLOYEES WITH NEEDLESTICK INJURIES ANNALS OF INTERNAL MEDICINE,115(5):367-369 1991 Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, Y; FURUTA, S; NISHIOKA, K; PURCELL, RH; ALTER, HJ
COMPARATIVE-STUDY OF CLINICAL, HISTOLOGICAL, AND IMMUNOLOGICAL RESPONSES TO INTERFERON THERAPY IN TYPE-NON-A, TYPE-NON-B, AND TYPE-B CHRONIC HEPATITIS AMERICAN JOURNAL OF GASTROENTEROLOGY,85(1):24-29 1990 Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E
PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA VOX SANGUINIS,59(2):86-88 1990 Author:WATANABE, J; MINEGISHI, K; MITSUMORI, T; ISHIFUJI, M; OGUCHI, T; UEDA, M; TOKUNAGA, E; TANAKA, E; KIYOSAWA, K; FURUTA, S; KATAYAMA, T; KUO, G; CHOO, QL; HOUGHTON, M; NISHIOKA, K
INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS HEPATOLOGY,12(4):671-675 1990 Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; GIBO, Y; YOSHIZAWA, K; NAKANO, Y; FURUTA, S; AKAHANE, Y; NISHIOKA, K; PURCELL, RH; ALTER, HJ
TRANSITION OF ANTIBODY TO HEPATITIS-C VIRUS FROM CHRONIC HEPATITIS TO HEPATOCELLULAR-CARCINOMA JAPANESE JOURNAL OF CANCER RESEARCH,81(11):1089-1091 1990 Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, K; USUDA, S; YOUSUF, M; FURUTA, S
Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection JGH Open Author:Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E